Clinical trials

  • IBRUTINIB for Follicular lymphoma|Chronic lymphocytic leukemia|Waldenstrom macroglobulinemia|Multiple myeloma|Marginal zone lymphoma|Diffuse large B-cell lymphoma|Urothelial carcinoma|Breast cancer|Acute myeloid leukemia|Graft versus host disease|Mantle cell lymphoma
  • RAPCABTAGENE AUTOLEUCEL for High-risk large B-cell lymphoma | Chronic lymphocytic leukemia | Small lymphocytic lymphoma | Diffuse large B-cell lymphoma | Acute lymphoblastic leukemia
  • GRT-001 for Ulcerative colitis
  • Trastuzumab; Pertuzumab for HER2-positive unresectable locally advanced or metastatic breast cancer | HER2-positive unresectable locally recurrent or metastatic breast cancer
  • belantamab mafodotin for Multiple myeloma
  • Apixaban for End-stage renal disease (on chronic peritoneal dialysis) | Non-valvular atrial fibrillation
  • AZD8421 for ER-positive HER2-negative advanced breast cancer | High-grade serous ovarian cancer
  • EMPASIPRUBART for Multifocal motor neuropathy
  • PEMBROLIZUMAB for Advanced solid tumors
  • METHOXYFLURANE 99.9% for Acute myocardial infarction
  • TOZORAKIMAB for Severe viral lung infections
  • PATIDEGIB HYDROCHLORIDE ISOPROPANOLATE for Gorlin syndrome|Basal cell carcinoma